Results 81 to 90 of about 441 (144)
Revista de Ciências Médicas e Biológicas
, 2010 p. 257-262A HAC é um distúrbio congênito, caracterizado pela deficiência na biossíntese do cortisol, associado ou não à deficiência de aldosterona e, consequentemente, à superprodução de andrógeno. Essa condição afeta igualmente homens e mulheres.
Silva, Célia Nunes +7 more
core
The Mineralocorticoid Receptor and the Heart
Endocrinology, 2021 Celso E Gomez-Sanchez +1 more
openaire +2 more sources
Corioretinopatia serosa central
La corioretinopatía serosa central (CSC) es una patología ocular caracterizada por la acumulación de líquido subretiniano, lo que provoca visión distorsionada y disminución de la agudeza visual.
Silva Aguayo, Diego Fernando +3 more
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Mineralocorticoid Hypertension
Lancet, The, 1999Hypertension with hypokalaemia and suppression of plasma renin activity is known as mineralocorticoid hypertension. Although mineralocorticoid hypertension accounts for a small number of patients labelled as having "essential" hypertension, it is a potentially reversible cause of high blood pressure.
Paul Stewart
exaly +3 more sources
Trends in Endocrinology and Metabolism, 2004
Mineralocorticoid resistance, also known as type I pseudohypoaldosteronism (PHA1), is a rare inherited disease characterized by salt wasting, dehydration and failure to thrive in the newborn. Two different forms of the disease, which present with either systemic or exclusively renal resistance to aldosterone, are associated with two different modes of ...
Maria-Christina, Zennaro, Marc, Lombès
openaire +2 more sources
Mineralocorticoid resistance, also known as type I pseudohypoaldosteronism (PHA1), is a rare inherited disease characterized by salt wasting, dehydration and failure to thrive in the newborn. Two different forms of the disease, which present with either systemic or exclusively renal resistance to aldosterone, are associated with two different modes of ...
Maria-Christina, Zennaro, Marc, Lombès
openaire +2 more sources
Steroids, 2000
The physiology of mineralocorticoid action, particularly with respect to epithelial sodium transport, is well defined. A full understanding of the molecular basis of mineralocorticoid action has however proven to be more elusive. In the last decade insights into structural and functional aspects of the mineralocorticoid receptor combined with emerging ...
F M, Rogerson, P J, Fuller
openaire +2 more sources
The physiology of mineralocorticoid action, particularly with respect to epithelial sodium transport, is well defined. A full understanding of the molecular basis of mineralocorticoid action has however proven to be more elusive. In the last decade insights into structural and functional aspects of the mineralocorticoid receptor combined with emerging ...
F M, Rogerson, P J, Fuller
openaire +2 more sources
Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension
Advances in Chronic Kidney Disease, 2015The mineralocorticoid aldosterone is a key hormone in the regulation of plasma volume and blood pressure in man. Excessive levels of this mineralocorticoid have been shown to mediate metabolic disorders and end-organ damage more than what can be attributed to its effects on blood pressure alone.
Sivakumar Ardhanari +4 more
openaire +2 more sources
Apparent Mineralocorticoid Excess
Trends in Endocrinology and Metabolism, 2001Apparent mineralocorticoid excess (AME) is a potentially fatal genetic disorder causing severe juvenile hypertension, pre- and postnatal growth failure, hypokalemia and low to undetectable levels of renin and aldosterone. It is caused by autosomal recessive mutations in the HSD11B2 gene, which result in a deficiency of 11 beta-hydroxysteroid ...
R C Wilson, Maria I New, M I New
exaly +3 more sources